Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Join our interdisciplinary faculty of clinicians, statisticians and trial managers with a wealth of RCT experience in this 16th year of the CSM RCT course

This course is ideal for anyone planning or actively involved in RCTs for healthcare evaluation, particularly those early in their career or looking for a refresher course
 Clinical and non-clinical researchers, other professionals allied to medicine, statisticians: all welcome
 Problem-based learning approach mixing lectures & small-group practical work
 Provides a thorough grounding in the principles and practice of all elements of an RCT, rooted in practical experience, the literature and best practice

This year the course is being held at Merton College at the University of Oxford from Monday 17th to Friday 22nd September.

Places are £1450

Enquiries and bookings should be to: +44 (0)1865 223447 or rct.course@csm.ox.ac.uk

Similar stories

Oxford receives NIHR funding to test anti-TNF on post operative delirium

Researchers at the University of Oxford have been awarded a grant from the National Institute for Health and Care Research (NIHR) to investigate whether anti-tumour necrosis factor (TNF) therapy can reduce or prevent post operative delirium/cognitive deficit.

Emergency departments to use the FORCE pathway for wrist fractures in children

New research from the University of Oxford has shown that doctors can simplify treatment for the most common fracture in children, reducing NHS costs.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Celebrating Clinical Trials Day at NDORMS

To mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain

A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.